|
|
Article: Dopaminergic treatment hallucinations not 'benign'.(Clinical Rounds)
- Article from:
- Family Practice News
- Article date:
- January 15, 2006
- Author:
CopyrightCOPYRIGHT 2006 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
SAN DIEGO -- So-called benign hallucinations associated with dopaminergic treatment for Parkinson's disease rarely remain "benign," calling into question the accuracy of the term.
Researchers at Rush University in Chicago studied the clinical progression of 48 patients with Parkinson's disease who were diagnosed with hallucinations characterized by the patient's retention of the insight that the hallucinations are unreal.
These hallucinations have been called benign, and traditionally have been associated with a Unified Parkinson Disease Rating Scale (UPDRS) Thought Disorder score of 2.
In 2 years, just 2 of the 48 patients at Rush continued to ...